FDA revokes EUAs for two SARS-CoV-2 tests

FDA revokes EUAs for two SARS-CoV-2 tests
kpage_drupal
Jun 27, 2022

The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test because no viable (non-expired) tests remain.
 

Headline

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Leave a comment